Evidence map›Paper›PMID 39251990›Full record

ArticleCell communication and signaling : CCS2024

Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.

Francesca Giammello, Chiara Biella, Erica Cecilia Priori, Matilde Amat Di San Filippo, Roberta Leone, Francesca D'Ambrosio, Martina Paterno', Giulia Cassioli, Antea Minetti, Francesca Macchi and 11 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Cancer: A bioelectric disease?Clinical and translational medicine · 2026
    Review
  5. Biomedicines · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Francesca Giammello *Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, 27100, Italy.
Chiara Biella *IRCCS San Raffaele Hospital, Via Olgettina 58, Milan, 20132, Italy.
Erica Cecilia PrioriDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, 27100, Italy.
Matilde Amat Di San FilippoDepartment of Biosciences, University of Milan, Milan, 20133, Italy.
Roberta LeoneDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, 27100, Italy.
Francesca D'AmbrosioDepartment of Biosciences, University of Milan, Milan, 20133, Italy.
Martina Paterno'Department of Biosciences, University of Milan, Milan, 20133, Italy.
Giulia CassioliDepartment of Biosciences, University of Milan, Milan, 20133, Italy.
Antea MinettiCNR Neuroscience Institute of Pisa, Via Giuseppe Moruzzi, 1, Pisa (PI), 56124, Italy.
Francesca MacchiCNR Neuroscience Institute of Pisa, Via Giuseppe Moruzzi, 1, Pisa (PI), 56124, Italy.
Cristina SpallettiCNR Neuroscience Institute of Pisa, Via Giuseppe Moruzzi, 1, Pisa (PI), 56124, Italy.
Ilaria MorellaDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, 27100, Italy.
Cristina RubertiAdvanced Technology Platform, Department of Biosciences, University of Milan, Milan, 20133, Italy.
Beatrice TremontiPharmacology Unit, Department of Internal Medicine, University of Genova, Genova, 16132, Italy.
Federica BarbieriPharmacology Unit, Department of Internal Medicine, University of Genova, Genova, 16132, Italy.
Giuseppe LombardiDepartment of Oncology 1, Oncology, Veneto Institute of Oncology IOV-IRCCS, via Gattamelata 64, Padua, 35128, Italy.
Riccardo BrambillaDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, 27100, Italy.
Tullio FlorioPharmacology Unit, Department of Internal Medicine, University of Genova, Genova, 16132, Italy.
Rossella GalliIRCCS San Raffaele Hospital, Via Olgettina 58, Milan, 20132, Italy.
Paola RossiDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, 27100, Italy.
Federico BrandaliseDepartment of Biosciences, University of Milan, Milan, 20133, Italy. federico.brandalise@unimi.it.

Funding

3Brain-The Massimo Grattarola Award 2022 LIB_VT22FBRANMinistero della Salute "Creazione di Hub delle Scienze della Vita" Project IMMUNOHUB,T4-CN-02Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2022WFMW5KMinistry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS PE0000006
6 · The paper itself

Abstract

backgroundGlioblastoma (GBM) stands as the most prevalent and aggressive form of adult gliomas. Despite the implementation of intensive therapeutic approaches involving surgery, radiation, and chemotherapy, Glioblastoma Stem Cells contribute to tumor recurrence and poor prognosis. The induction of Glioblastoma Stem Cells differentiation by manipulating the transcriptional machinery has emerged as a promising strategy for GBM treatment. Here, we explored an innovative approach by investigating the role of the depolarized resting membrane potential (RMP) observed in patient-derived GBM sphereforming cell (GSCs), which allows them to maintain a stemness profile when they reside in the G0 phase of the cell cycle.

methodsWe conducted molecular biology and electrophysiological experiments, both in vitro and in vivo, to examine the functional expression of the voltage-gated sodium channel (Na

resultsWe demonstrated that Na

conclusionsThis insight positions Na

Indexed as

Cell DifferentiationGlioblastomaNeoplastic Stem CellsVoltage-Gated Sodium ChannelsAnimalsBrain NeoplasmsCell Line, TumorCell ProliferationHumansMiceTemozolomideTemozolomideVoltage-Gated Sodium ChannelsCANCER STEM CELLSERKGBMMAPKNavRESTING MEMBRANE POTENTIALTMZTTX; CHEMOTHERAPY

Identifiers

PMID39251990
PMCPMC11382371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.